Abukhalil Abdallah Damin, Alyan Motaz, AbuAita Woroud, Al-Shami Ni'meh, Naseef Hani A
Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Birzeit, West Bank, Palestine.
Patient Prefer Adherence. 2022 Aug 2;16:1855-1863. doi: 10.2147/PPA.S376000. eCollection 2022.
Diabetes mellitus (D.M.) is a chronic metabolic disease caused by decreased insulin secretion, which increases the risk of cardiovascular diseases. Evidence has shown that statins reduce cardiovascular risk in patients with diabetes; moreover, most clinical guidelines recommend statins.
This study aimed to assess the level and status of adherence to guidelines on statin prescription in patients with diabetes mellitus in a primary care setting in Palestine.
A retrospective cross-sectional descriptive study was conducted at an ambulatory center in Palestine. Data were collected by auditing prescription records and reviewing medical charts of patients with diabetes who visited the clinic from February 15 to March 17, 2021. The collected data included patient characteristics, comorbidities, lipid profiles, and statin prescription. A chi-square test was used to evaluate the appropriateness of the prescribed statins with different demographic and clinical variables. Statistical significance was set at p < 0.05. Statistical Package for Social Sciences (SPSS) version 22 was used to analyze the data.
Out Of 262 diabetic patients included in the analysis, 74% were prescribed appropriate statin therapy according to the American Diabetes Association (ADA) guidelines, and 24% of patients had inappropriate statin therapy or needed statins. Furthermore, 82.8% were on high-intensity statins, while 11% were not taking any statins. More than 60% of patients had uncontrolled diabetes and hypertension.
Most guidelines recommend statin therapy in diabetic patients owing to its benefits in preventing cardiovascular complications. In this study, most patients were on appropriate STATIN therapy; however, 50% of diabetic patients had LDL of more than 100 mg/dl, and 25% were not prescribed statins, increasing their risk of ASCVD. Therefore, we recommend strict adherence to the established guidelines on statins prescribed to patients with diabetes to prevent cardiovascular complications, save lives, and reduce healthcare costs.
糖尿病是一种由胰岛素分泌减少引起的慢性代谢性疾病,会增加心血管疾病的风险。有证据表明,他汀类药物可降低糖尿病患者的心血管风险;此外,大多数临床指南都推荐使用他汀类药物。
本研究旨在评估巴勒斯坦基层医疗环境中糖尿病患者他汀类药物处方指南的遵循水平和状况。
在巴勒斯坦的一个门诊中心进行了一项回顾性横断面描述性研究。通过审核处方记录和查阅2021年2月15日至3月17日到该诊所就诊的糖尿病患者的病历收集数据。收集的数据包括患者特征、合并症、血脂谱和他汀类药物处方。采用卡方检验评估所开他汀类药物与不同人口统计学和临床变量的适宜性。设定统计学显著性为p < 0.05。使用社会科学统计软件包(SPSS)22版分析数据。
在纳入分析的262例糖尿病患者中,74%的患者根据美国糖尿病协会(ADA)指南接受了适当的他汀类药物治疗,24%的患者接受了不适当的他汀类药物治疗或需要使用他汀类药物。此外,82.8%的患者使用高强度他汀类药物,而11%的患者未服用任何他汀类药物。超过60%的患者糖尿病和高血压未得到控制。
由于他汀类药物在预防心血管并发症方面的益处,大多数指南推荐对糖尿病患者进行他汀类药物治疗。在本研究中,大多数患者接受了适当的他汀类药物治疗;然而,50%的糖尿病患者低密度脂蛋白超过100mg/dl,25%的患者未开具他汀类药物,增加了他们发生动脉粥样硬化性心血管疾病(ASCVD)的风险。因此,我们建议严格遵循为糖尿病患者制定的他汀类药物处方指南,以预防心血管并发症、挽救生命并降低医疗成本。